Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian Group

Eur Urol. 1999:35 Suppl 1:17-21; discussion 22. doi: 10.1159/000052302.

Abstract

Objective: This prospective, randomized, multicenter comparative trial studied the effect of neoadjuvant hormonal treatment (NHT) prior to radical, prostatectomy.

Methods: Histopathologic tissue specimens were obtained from 91 consecutive patients (aged 60-70 years) who underwent a radical prostatectomy for stage B prostate adenocarcinoma. The patients had received NHT for three months. Specimens were compared with those from 48 age-matched control patients who underwent similar surgery for stage B disease without receiving preoperative therapy.

Results: Treated tumors with an acinar pattern were distinguishable from the untreated tumors by neoplastic acini that appeared shrunken and areas of individual infiltrating tumor cells separated by an abundant interglandular connective tissue. The epithelial tumor cells had inconspicuous nucleoli, nuclear shrinkage, chromatin condensation and pyknosis, cytoplasmic clearing, and enlargement by coalescence of vacuoles and rupture of cell membranes. No mitotic figures were seen in any treated tumors.

Conclusions: Preliminary results show a benefit for patients receiving NHT in regard to the histologic indicators that we evaluated.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Aged
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Chemotherapy, Adjuvant
  • Cyproterone Acetate / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Leuprolide / therapeutic use
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Prospective Studies
  • Prostatectomy*
  • Prostatic Hyperplasia / drug therapy
  • Prostatic Hyperplasia / pathology
  • Prostatic Hyperplasia / surgery
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery*

Substances

  • Antineoplastic Agents, Hormonal
  • Cyproterone Acetate
  • Leuprolide